Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

Edgewood Oncology

HQ: Brookline, MA source · edgewoodoncology.com ↗

Clinical Phase 1

Location: Brookline, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Metastatic Breast Cancer Acute Myeloid Leukemia Myelodysplastic Syndrome BTX-A51

2Trials (company is sponsor)

Timeline

Jun 7, 2021 Trial start Phase 1: A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer source ↗
Jan 6, 2020 Trial start Phase 1: A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome source ↗

Clinical trials (lead sponsor) 2

Record	Title	Phase	Status	Start	Primary completion
NCT04872166	A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer	Phase 1	Recruiting	Jun 7, 2021	2026-05 (estimated)
NCT04243785	A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome	Phase 1	Recruiting	Jan 6, 2020	2026-03 (estimated)